Minnesota providers participating in the federal 340B Drug Pricing Program generated at least $630 million in net revenue in 2023, according to a new report from the state Department of Health.

Pushback against a decades-old federal program that provides savings on prescription drugs to certain hospitals and health ...

The Minnesota Department of Health recently unveiled a pivotal report on the 340B drug pricing program, which provides ...

Minnesota releases a report on the 340B Drug Pricing Program, highlighting the need for transparency in healthcare economics.

according to a report from the Minnesota Department of Health. Specifically, hospitals received $1.5 billion in discounted medicines under the 340B Drug Discount program, but paid $734 million ...

The Minnesota Department of Health has released data detailing more than $600 million in extra revenue that hospitals received from a program known as “340B,” which exists to help safety-net ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover Wegovy and Zepbound ...

“The recent report on 340B purchases by Minnesota hospitals is beginning to expose how big hospital systems and their contract pharmacies are using the 340B program to pad their profits at the e ...